Cargando…
EOAI, a ubiquitin-specific peptidase 5 inhibitor, prevents non-small cell lung cancer progression by inducing DNA damage
OBJECTIVE: Targeting deubiquitinases (DUBs) has emerged as a promising avenue for anticancer drug development. However, the effect and mechanism of pan-DUB inhibitor EOAI on non-small cell lung cancer (NSCLC) remains to be studied. MATERIALS AND METHODS: The expression of ubiquitin-specific peptidas...
Autores principales: | Zheng, Yuanyuan, Wang, Longhao, Niu, Xiaoyu, Guo, Yongjun, Zhao, Jiuzhou, Li, Lifeng, Zhao, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826599/ https://www.ncbi.nlm.nih.gov/pubmed/36611139 http://dx.doi.org/10.1186/s12885-023-10506-0 |
Ejemplares similares
-
The role of ubiquitin-specific peptidases in cancer progression
por: Young, Ming-Jer, et al.
Publicado: (2019) -
Ubiquitin specific peptidases and prostate cancer
por: Guo, Yunfei, et al.
Publicado: (2023) -
Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors
por: Chen, Shiyao, et al.
Publicado: (2021) -
Expression and Role of Ubiquitin-Specific Peptidases in Osteoblasts
por: Hariri, Hadla, et al.
Publicado: (2021) -
Ubiquitin‐specific peptidases: Players in bone metabolism
por: Shen, Jianlin, et al.
Publicado: (2023)